Analyst Ratings for Arcutis Biotherapeutics

Doris

Around the earlier 3 months, 4 analysts have printed their belief on Arcutis Biotherapeutics ARQT stock. These analysts are usually used by significant Wall Avenue banking institutions and tasked with being familiar with a company’s company to predict how a inventory will trade over the impending calendar year.

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

&#13

  Bullish To some degree Bullish Indifferent To some degree Bearish Bearish
Complete Scores 1 3
Very last 30D 1 1
1M Back
2M Back 1
3M In the past 1

These 4 analysts have an typical selling price goal of $42.5 versus the present selling price of Arcutis Biotherapeutics at $20.26, implying upside.

Underneath is a summary of how these 4 analysts rated Arcutis Biotherapeutics above the previous 3 months. The bigger the number of bullish scores, the extra beneficial analysts are on the inventory and the better the variety of bearish ratings, the extra damaging analysts are on the inventory

This average value goal has enhanced by 8.28% in excess of the earlier month.

If you are intrigued in subsequent tiny-cap inventory information and functionality you can commence by tracking it listed here.

Benzinga tracks 150 analyst firms and stories on their stock anticipations. Analysts normally get there at their conclusions by predicting how a great deal funds a firm will make in the future, generally the future five many years, and how risky or predictable that firm’s revenue streams are.

Analysts go to business conference phone calls and meetings, investigate business money statements, and connect with insiders to publish their ratings on stocks. Analysts commonly price each individual stock after per quarter or each time the firm has a major update.

Some analysts also present predictions for practical metrics such as earnings, revenue, and growth estimates to provide further steering as to what to do with sure tickers. It is essential to retain in mind that even though stock and sector analysts are professionals, they are also human and can only forecast their beliefs to traders.

This posting was generated by Benzinga’s automatic content engine and reviewed by an editor.

Next Post

Why Cognex (CGNX) Shares Are Falling Afterhours Today

Cognex Company CGNX reported next-quarter earnings progress of 2% year-above-12 months to $274.63 million, lacking the consensus of $276.59 million. Modified EPS was $.41, missing the consensus of $.42. The gross margin declined to 72% as opposed with 75% in 2Q21. Operating earnings reduced 29.6% Y/Y to $65.14 million, and margin fell […]

Subscribe US Now